These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 8639180)
1. Prevention and reversal of cartilage degradation in rheumatoid arthritis by interleukin-10 and interleukin-4. van Roon JA; van Roy JL; Gmelig-Meyling FH; Lafeber FP; Bijlsma JW Arthritis Rheum; 1996 May; 39(5):829-35. PubMed ID: 8639180 [TBL] [Abstract][Full Text] [Related]
2. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion. Woolley DE; Tetlow LC Arthritis Res; 2000; 2(1):65-74. PubMed ID: 11219391 [TBL] [Abstract][Full Text] [Related]
3. Proinflammatory cytokine production and cartilage damage due to rheumatoid synovial T helper-1 activation is inhibited by interleukin-4. van Roon JA; van Roy JL; Duits A; Lafeber FP; Bijlsma JW Ann Rheum Dis; 1995 Oct; 54(10):836-40. PubMed ID: 7492224 [TBL] [Abstract][Full Text] [Related]
4. Interleukin-4 and interleukin-10 are chondroprotective and decrease mononuclear cell recruitment in human rheumatoid synovium in vivo. Jorgensen C; Apparailly F; Couret I; Canovas F; Jacquet C; Sany J Immunology; 1998 Apr; 93(4):518-23. PubMed ID: 9659224 [TBL] [Abstract][Full Text] [Related]
5. Suppression of human cartilage proteoglycan synthesis by rheumatoid synovial fluid mononuclear cells activated with mycobacterial 60-kd heat-shock protein. Wilbrink B; Holewijn M; Bijlsma JW; van Roy JL; den Otter W; van Eden W Arthritis Rheum; 1993 Apr; 36(4):514-8. PubMed ID: 8457226 [TBL] [Abstract][Full Text] [Related]
6. Role of interleukin-1, tumor necrosis factor alpha, and interleukin-6 in cartilage proteoglycan metabolism and destruction. Effect of in situ blocking in murine antigen- and zymosan-induced arthritis. van de Loo FA; Joosten LA; van Lent PL; Arntz OJ; van den Berg WB Arthritis Rheum; 1995 Feb; 38(2):164-72. PubMed ID: 7848306 [TBL] [Abstract][Full Text] [Related]
7. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis. Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663 [TBL] [Abstract][Full Text] [Related]
8. In vitro effects of methotrexate on human articular cartilage and bone-derived osteoblasts. van der Veen MJ; Scheven BA; van Roy JL; Damen CA; Lafeber FP; Bijlsma JW Br J Rheumatol; 1996 Apr; 35(4):342-9. PubMed ID: 8624637 [TBL] [Abstract][Full Text] [Related]
9. Predominant cellular immune response to the cartilage autoantigenic G1 aggrecan in ankylosing spondylitis and rheumatoid arthritis. Zou J; Zhang Y; Thiel A; Rudwaleit M; Shi SL; Radbruch A; Poole R; Braun J; Sieper J Rheumatology (Oxford); 2003 Jul; 42(7):846-55. PubMed ID: 12730543 [TBL] [Abstract][Full Text] [Related]
10. The elevated ratio of interferon gamma-/interleukin-4-positive T cells found in synovial fluid and synovial membrane of rheumatoid arthritis patients can be changed by interleukin-4 but not by interleukin-10 or transforming growth factor beta. Yin Z; Siegert S; Neure L; Grolms M; Liu L; Eggens U; Radbruch A; Braun J; Sieper J Rheumatology (Oxford); 1999 Nov; 38(11):1058-67. PubMed ID: 10556256 [TBL] [Abstract][Full Text] [Related]
11. Cytokine stimulation of T lymphocytes regulates their capacity to induce monocyte production of tumor necrosis factor-alpha, but not interleukin-10: possible relevance to pathophysiology of rheumatoid arthritis. Sebbag M; Parry SL; Brennan FM; Feldmann M Eur J Immunol; 1997 Mar; 27(3):624-32. PubMed ID: 9079801 [TBL] [Abstract][Full Text] [Related]
12. The stimulation of mononuclear cells from patients with rheumatoid arthritis to degrade articular cartilage is not modulated by cartilage itself. van Roon JA; van Roy JL; Lafeber FP; Bijlsma JW Clin Exp Rheumatol; 1996; 14(2):177-82. PubMed ID: 8737724 [TBL] [Abstract][Full Text] [Related]
13. [Proinflammatory cytokine interleukin-17 and its role in pathogenesis of rheumatoid arthritis]. Leonaviciene L; Bradūnaite R; Astrauskas V Medicina (Kaunas); 2004; 40(5):419-22. PubMed ID: 15170409 [TBL] [Abstract][Full Text] [Related]
14. Interleukin-1 receptor antagonist inhibits proteoglycan breakdown in antigen induced but not polycation induced arthritis in the rabbit. Arner EC; Harris RR; DiMeo TM; Collins RC; Galbraith W J Rheumatol; 1995 Jul; 22(7):1338-46. PubMed ID: 7562769 [TBL] [Abstract][Full Text] [Related]
15. Comparative and combined effects of interleukin 6, interleukin 1 beta, and tumor necrosis factor alpha on proteoglycan metabolism of human articular chondrocytes cultured in agarose. Malfait AM; Verbruggen G; Veys EM; Lambert J; De Ridder L; Cornelissen M J Rheumatol; 1994 Feb; 21(2):314-20. PubMed ID: 8182643 [TBL] [Abstract][Full Text] [Related]
16. Osteoarthritis and rheumatoid arthritis pannus have similar qualitative metabolic characteristics and pro-inflammatory cytokine response. Furuzawa-Carballeda J; Macip-Rodríguez PM; Cabral AR Clin Exp Rheumatol; 2008; 26(4):554-60. PubMed ID: 18799084 [TBL] [Abstract][Full Text] [Related]
17. The role of cytokines in osteoarthritis pathophysiology. Fernandes JC; Martel-Pelletier J; Pelletier JP Biorheology; 2002; 39(1-2):237-46. PubMed ID: 12082286 [TBL] [Abstract][Full Text] [Related]
18. Cytokine profile of autologous conditioned serum for treatment of osteoarthritis, in vitro effects on cartilage metabolism and intra-articular levels after injection. Rutgers M; Saris DB; Dhert WJ; Creemers LB Arthritis Res Ther; 2010; 12(3):R114. PubMed ID: 20537160 [TBL] [Abstract][Full Text] [Related]
19. Apocynin, a plant-derived, cartilage-saving drug, might be useful in the treatment of rheumatoid arthritis. Lafeber FP; Beukelman CJ; van den Worm E; van Roy JL; Vianen ME; van Roon JA; van Dijk H; Bijlsma JW Rheumatology (Oxford); 1999 Nov; 38(11):1088-93. PubMed ID: 10556260 [TBL] [Abstract][Full Text] [Related]